Immediate Impact

1 by Nobel laureates 9 from Science/Nature 68 standout
Sub-graph 1 of 22

Citing Papers

Natural killer cell therapies
2024 StandoutNature
Naturally occurring T cell mutations enhance engineered T cell therapies
2024 StandoutNature
2 intermediate papers

Works of Anthony Jarkowski being referenced

CA045-001: A phase III, randomized, open label study of bempegaldesleukin (NKTR-214) plus nivolumab (NIVO) versus NIVO monotherapy in patients (pts) with previously untreated, unresectable or metastatic melanoma (MEL).
2019
Retrospective Analysis of the Safety and Efficacy of High-dose Interleukin-2 After Prior Tyrosine Kinase Inhibitor Therapy in Patients With Advanced Renal Cell Carcinoma
2014

Author Peers

Author Last Decade Papers Cites
Anthony Jarkowski 250 89 126 248 174 28 688
Luning Zhuang 105 59 177 234 142 24 628
Srividya Kotapati 284 44 101 165 139 34 611
Naoki Matsumura 191 89 153 173 93 42 670
Lena M. Biehl 142 37 244 165 256 28 767
Vasiliki Rapti 63 42 119 193 104 29 733
David Hines 106 49 75 152 293 30 750
A. Benouda 67 46 133 261 133 16 713
Teresa Tórtola 111 29 64 316 418 39 831
Irfan Ali Mirza 126 39 78 241 184 45 603
Trish Dinh 129 50 187 134 114 31 717

All Works

Loading papers...

Rankless by CCL
2026